Literature DB >> 12508373

Effects of Tetrandrine and QYT on ICAM-1 and SOD gene expression in pancreas and liver of rats with acute pancreatitis.

Yong-Yu Li1, Xue-Li Li, Cui-Xiang Yang, Hong Zhong, Hong Yao, Ling Zhu.   

Abstract

AIM: Available experimental evidence from both clinical and animal models shows that both Chinese medicines tetrandine (Tet) and Qing Yi Tong (QYT) have positive treatment effects on acute pancreatitis (AP). This investigation was conducted to explore the treatment mechanisms of Tet and QYT on AP at the molecular level and thereby explain their therapeutic affects. It included an investigation of the effects of these drugs on gene expression of both intercellular adhesion molecule 1 (ICAM-1) and superoxide dismutase (Mn-SOD and Cu, Zn-SOD) in a rat model with AP.
METHODS: AP in the test rats was induced by subjecting them to laparotomy followed by a retrograde injection of 4 % sodium taurocholate into the bilio-pancreatic duct. The test rats with AP were divided into three groups. One was treated with Tet, one with QYT, and one with normal saline solution. The sham-operated control group (SO) rats were only subjected to laparotomy. They were given no further treatment. For the Tet group, Tet was injected intraperitoneally, and for the QYT group, QYT was given with a nose-gastric catheter. These procedures were done at both 10 min and 5 h after AP induction. The levels of ICAM-1 mRNA expression and of SOD (Mn-SOD and Cu, Zn-SOD) mRNA expression in the pancreas and liver tissues were measured by RT-PCR at 1, 5, and 10 h after AP induction.
RESULTS: When compared with the SO group during the observation time, rats with AP showed a higher expression of ICAM and a lower expression of Mn-SOD in both pancreas and liver tissues, and a lower expression of Cu, Zn-SOD in the pancreas. Tet treatment attenuated changes in the expression of both ICAM-1, and SOD (Mn-SOD and Cu, Zn-SOD) to a significant degree. A similar effect on the expression of SOD (Mn-SOD and Cu, Zn-SOD) was also found in the QYT group, but no obvious suppressive effect on ICAM-1 expression was observed.
CONCLUSION: The results of this study suggest that one of the main mechanisms of Tet and QYT in treating AP is to enhance anti-oxidation of the body. The results also suggest that the anti-inflammatory effect of Tet is involved in the reduction of ICAM-1 expression. This explains why Tet and QYT are beneficial in treating AP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508373      PMCID: PMC4728232          DOI: 10.3748/wjg.v9.i1.155

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block?

Authors:  Guido Eibl; Heinz J Buhr; Thomas Foitzik
Journal:  Intensive Care Med       Date:  2002-01-17       Impact factor: 17.440

2.  Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of NF-kappaB and AP-1 in septic rats.

Authors:  C K Chang; M V Albarillo; W Schumer
Journal:  J Surg Res       Date:  2001-02       Impact factor: 2.192

3.  Specific induction of adhesion molecules in human vascular endothelial cells by rat experimental pancreatitis-associated ascitic fluids.

Authors:  A Masamune; T Shimosegawa; K Kimura; M Fujita; A Sato; M Koizumi; T Toyota
Journal:  Pancreas       Date:  1999-03       Impact factor: 3.327

4.  Elastase mimics pancreatitis-induced hepatic injury via inflammatory mediators.

Authors:  C Jaffray; J Yang; J Norman
Journal:  J Surg Res       Date:  2000-05-15       Impact factor: 2.192

5.  Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?

Authors:  B Rau; B Poch; F Gansauge; A Bauer; A K Nüssler; T Nevalainen; M H Schoenberg; H G Beger
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

6.  Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome.

Authors:  C Jaffray; J Yang; G Carter; C Mendez; J Norman
Journal:  Surgery       Date:  2000-08       Impact factor: 3.982

7.  Differential upregulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis.

Authors:  G Telek; R Ducroc; J Y Scoazec; C Pasquier; G Feldmann; C Rozé
Journal:  J Surg Res       Date:  2001-03       Impact factor: 2.192

8.  Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells.

Authors:  V Zaninovic; A S Gukovskaya; I Gukovsky; M Mouria; S J Pandol
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-10       Impact factor: 4.052

9.  Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers.

Authors:  B Rau; A Bauer; A Wang; F Gansauge; H Weidenbach; T Nevalainen; B Poch; H G Beger; A K Nussler
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

10.  Nitric oxide decreases endothelial activation by rat experimental severe pancreatitis-associated ascitic fluids.

Authors:  A Masamune; T Shimosegawa; A Satoh; M Fujita; Y Sakai; T Toyota
Journal:  Pancreas       Date:  2000-04       Impact factor: 3.327

View more
  10 in total

1.  Alteration of chaperonin60 and pancreatic enzyme in pancreatic acinar cell under pathological condition.

Authors:  Yong-Yu Li; Moise Bendayan
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion.

Authors:  Juan Pablo Mackern-Oberti; Mariana Maccioni; Cecilia Cuffini; Gerardo Gatti; Virginia E Rivero
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

3.  Systemic injury caused by taurocholate-induced severe acute pancreatitis in rats.

Authors:  Xin-Xin Hong; Hong-Yan Wang; Jiong-Ming Yang; Bao-Fu Lin; Qin-Qin Min; Yi-Zhong Liang; Pei-Di Huang; Zi-You Zhong; Shao-Ju Guo; Bin Huang; Yi-Fei Xu
Journal:  Exp Ther Med       Date:  2022-05-26       Impact factor: 2.751

4.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

5.  Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver.

Authors:  Zhongmin Liu; Zhenping Xu; Wenlu Shen; Yi Li; Jun Zhang; Xin Ye
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

6.  Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis.

Authors:  Xi Ping Zhang; Ling Zhang; Ping Yang; Rui Ping Zhang; Qi Hui Cheng
Journal:  Dig Dis Sci       Date:  2007-06-05       Impact factor: 3.199

7.  Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury.

Authors:  Deng Wenhong; Yu Jia; Wang Weixing; Chen Xiaoyan; Chen Chen; Xu Sheng; Jin Hao
Journal:  Mediators Inflamm       Date:  2012-03-05       Impact factor: 4.711

8.  Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects.

Authors:  Jie Xiong; Kezhou Wang; Chunxiao Yuan; Rong Xing; Jianbo Ni; Guoyong Hu; Fengling Chen; Xingpeng Wang
Journal:  Int J Mol Med       Date:  2016-11-22       Impact factor: 4.101

Review 9.  The potential of tetrandrine as a protective agent for ischemic stroke.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  Molecules       Date:  2011-09-16       Impact factor: 4.411

10.  Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1.

Authors:  Jun Wang; Ming Guo; Ruojia Ma; Maolin Wu; Yamei Zhang
Journal:  PeerJ       Date:  2020-05-07       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.